A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature

• Publication date

  2011-04-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nature09860PMID 21441910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemical Genetic Approach for Kinase‐Substrate Mapping by Covalent Capture of Thiophosphopeptides and Analysis by Mass Spectrometry

  2010cited by this paper
• ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

  2010cited by this paper
• Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.

  2009cited by this paper
• Signaling dynamics of the KSR1 scaffold complex

  2009cited by this paper
• Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors.

  2009cited by this paper
• A dimerization-dependent mechanism drives RAF catalytic activation

  2009cited by this paper
• RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer.

  2009cited by this paper
• Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3

  2009cited by this paper
• Quantitative Analysis of Synaptic Phosphorylation and Protein Expression*S

  2008cited by this paper
• Tuning a three-component reaction for trapping kinase substrate complexes.

  2008cited by this paper
• A semisynthetic epitope for kinase substrates

  2007cited by this paper
• Production of selenomethionyl‐derivatized proteins in baculovirus‐infected insect cells

  2007cited by this paper
• KSR and CNK: two scaffolds regulating RAS-mediated RAF activation

  2007cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• A KSR/CNK complex mediated by HYP, a novel SAM domain-containing protein, regulates RAS-dependent RAF activation in Drosophila.

  2006cited by this paper
• Coordinating ERK/MAPK signalling through scaffolds and inhibitors

  2005cited by this paper
• Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

  2004cited by this paper
• 3DCoffee@igs: a web server for combining sequences and structures into a multiple sequence alignment

  2004cited by this paper
• Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition

  2004cited by this paper
• CaspR: a web server for automated molecular replacement using homology modelling

  2004cited by this paper
• Improvement of the GenTHREADER Method for Genomic Fold Recognition

  2003cited by this paper
• A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer

  2002cited by this paper
• KSR is a scaffold required for activation of the ERK/MAPK module.

  2002cited by this paper
• Identification of B-KSR1, a Novel Brain-Specific Isoform of KSR1 That Functions in Neuronal Signaling

  2000cited by this paper
• Kinase Suppressor of Ras Forms a Multiprotein Signaling Complex and Modulates MEK Localization

  1999cited by this paper
• The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk‐1 phosphorylation from MAP kinase activation

  1998cited by this paper
• Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK.

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Murine Ksr interacts with MEK and inhibits Ras-induced transformation.

  1998cited by this paper
• Kinase suppressor of Ras is ceramide-activated protein kinase.

  1997cited by this paper
• KSR stimulates Raf-1 activity in a kinase-independent manner.

  1997cited by this paper
• Three-dimensional structure of the tyrosine kinase c-Src

  1997cited by this paper
• KSR modulates signal propagation within the MAPK cascade.

  1996cited by this paper
• The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction.

  1995cited by this paper
• KSR, a novel protein kinase required for RAS signal transduction.

  1995cited by this paper
• The ksr-7 Gene Encodes a Novel Protein Kinase Involved in Ras-Mediated Signaling in C. elegans

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper

• Kinase signaling cascades: an updated mechanistic landscape

  2025cites this paper
• An atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.

  2025cites this paper
• ERK pathway reactivation prevents anthrax toxin lethality in mice

  2025cites this paper
• PRAG1 promotes cholangiocyte epithelial-mesenchymal transition and liver fibrosis in biliary atresia.

  2025cites this paper
• ERK1/2-MAPK signaling: Metabolic, organellar, and cytoskeletal interactions.

  2025cites this paper
• Structural and evolutionary insights into understudied bacterial serine–threonine pseudokinase families

  2025cites this paper
• Structural basis for MEKK2 dimerization and substrate recognition

  2025cites this paper
• MAPK Pathway Inhibition Reshapes Kinase Chemical Probe Reactivity Reflecting Cellular Activation States

  2025cites this paper
• The CNK–HYP scaffolding complex promotes RAF activation by enhancing KSR–MEK interaction

  2024cites this paper
• Signaling from RAS to RAF: The Molecules and Their Mechanisms.

  2024cites this paper
• DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma

  2024cites this paper
• The bta-miR-22-3p can alleviate LPS-induced inflammatory response in yak endometrial epithelial cells by targeting KSR2.

  2024cites this paper
• Evolutionary history of MEK1 illuminates the nature of cancer and RASopathy mutations

  2023cites this paper
• Evolutionary history of MEK1 illuminates the nature of deleterious mutations

  2023cites this paper
• Navigating the ERK1/2 MAPK Cascade

  2023influential citation
• Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

  2023cites this paper
• Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma

  2023cites this paper
• Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling

  2023cites this paper
• Architecture of the MKK6-p38α complex defines the basis of MAPK specificity and activation

  2023influential citation
• Evaluating the Pharmacokinetics and Pharmacodynamics of Chemotherapeutics within a Spatial SILAC-Labeled Spheroid Model System.

  2023cites this paper
• Interaction between Rumen Epithelial miRNAs-Microbiota-Metabolites in Response to Cold-Season Nutritional Stress in Tibetan Sheep

  2023cites this paper
• RAS‐targeted cancer therapy: Advances in drugging specific mutations

  2023cites this paper
• Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species

  2023cites this paper
• Scaffold proteins as dynamic integrators of biological processes

  2022influential citation
• KSR2 promotes self-renewal and clonogenicity of small-cell lung carcinoma

  2022influential citation
• The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers.

  2022cites this paper
• Improving care of melanoma patients through efficient, integrated cellular-molecular pathology workflows using tissue samples with low tumour nuclear content

  2022cites this paper
• MAPK Signaling Pathway Is Essential for Female Reproductive Regulation in the Cabbage Beetle, Colaphellus bowringi

  2022cites this paper
• KSR induces RAS‐independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors

  2022cites this paper
• RAS: Circuitry and therapeutic targeting.

  2022cites this paper
• Recent advances in targeting protein kinases and pseudokinases in cancer biology

  2022cites this paper
• A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer.

  2022cites this paper
• Looking lively: emerging principles of pseudokinase signaling.

  2022cites this paper
• The mechanism of activation of MEK1 by B-Raf and KSR1

  2022cites this paper
• KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma

  2022influential citation
• Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.

  2022cites this paper
• Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance

  2022cites this paper
• Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer

  2022cites this paper
• Modulating undruggable targets to overcome cancer therapy resistance.

  2021cites this paper
• Signalling dynamics in embryonic development

  2021cites this paper
• New insights into Raf regulation from structural analyses.

  2021cites this paper
• Pseudokinases: Prospects for expanding the therapeutic targets armamentarium.

  2021cites this paper
• Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma

  2021influential citation
• Fic and non-Fic AMPylases: protein AMPylation in metazoans

  2021cites this paper
• There’s more to death than life: Noncatalytic functions in kinase and pseudokinase signaling

  2021influential citation
• Molecular mechanisms underlying cellular effects of human MEK1 mutations

  2021cites this paper
• Allosteric MEK inhibitors act on BRAF/MEK complexes to block MEK activation

  2021cites this paper
• Characterizing an allosteric inhibitor-induced inactive state in with-no-lysine kinase 1 using Gaussian accelerated molecular dynamics simulations.

  2021cites this paper
• Stochastic modulation evidences a transitory EGF-Ras-ERK MAPK activity induced by PRMT5

  2021cites this paper
• Pseudokinases repurpose flexibility signatures associated with the protein kinase fold for noncatalytic roles

  2021influential citation
• A TOR (target of rapamycin) and nutritional phosphoproteome of fission yeast reveals novel targets in networks conserved in humans

  2021cites this paper
• Xenopus Models of Organogenesis and Disease

  2020cites this paper
• BRAF

  2020cites this paper
• Structural basis for the action of the drug trametinib at KSR-bound MEK

  2020cites this paper
• The PEAK family of pseudokinases, their role in cell signalling and cancer

  2020cites this paper
• Identifying patient-specific flow of signal transduction perturbed by multiple single-nucleotide alterations

  2020cites this paper
• Conformational Dynamics Analysis of MEK1 Using Hydrogen/Deuterium Exchange Mass Spectrometry.

  2020cites this paper
• Prognostic value of BRAF/MIR‐17 signature and B‐Raf protein expression in patients with colorectal cancer: A pilot study

  2020cites this paper
• Hereditary Hearing Impairment with Cutaneous Abnormalities

  2020cites this paper
• Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues

  2020cites this paper
• Genome‐wide and structural analyses of pseudokinases encoded in the genome of Arabidopsis thaliana provide functional insights

  2020influential citation
• Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

  2020cites this paper
• A small molecule inhibitor of HER3: a proof-of-concept study

  2020cites this paper
• Targeting Oncogenic BRAF: Past, Present, and Future

  2019cites this paper
• A YWHAZ Variant Associated With Cardiofaciocutaneous Syndrome Activates the RAF-ERK Pathway

  2019cites this paper
• Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression

  2019cites this paper
• Ras-Mediated Activation of the Raf Family Kinases.

  2019influential citation
• Challenges in the annotation of pseudoenzymes in databases: the UniProtKB approach

  2019cites this paper
• RAS: Striking at the Core of the Oncogenic Circuitry

  2019cites this paper
• Protein polyglutamylation catalyzed by the bacterial calmodulin-dependent pseudokinase SidJ

  2019cites this paper
• Growth factor and receptor malfunctions associated with human genetic deafness

  2019cites this paper
• Divergent kinase regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole

  2019cites this paper
• How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study

  2019cites this paper
• Disordered Protein Kinase Regions in Regulation of Kinase Domain Cores.

  2019cites this paper
• Functional characterization of PEAK3/C19orf35 pseudokinase and its role in regulation of CrkII-dependent signaling

  2019cites this paper
• An acute encephalopathy with reduced diffusion in BRAF-associated cardio-facio-cutaneous syndrome.

  2019cites this paper
• Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

  2019cites this paper
• BRAF mutations as a therapeutic target in metastatic colorectal cancer patients: a long due success

  2019cites this paper
• Comprehensive Analysis of ERK1/2 Substrates for Potential Combination Immunotherapies.

  2019cites this paper
• A Central Region of NEMO is Required for IKKβ-Induced Conformational Change and for Signal Propagation.

  2019cites this paper
• Prospects for pharmacological targeting of pseudokinases

  2019cites this paper
• Platinum-Based Modification of Styrylbenzylsulfones as Multifunctional Antitumor Agents: Targeting RAS-RAF Pathway, Enhancing Antitumor Activity and Overcoming Multidrug Resistance.

  2019cites this paper
• Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives

  2019cites this paper
• A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole

  2018cites this paper
• Redefining the Protein Kinase Conformational Space with Machine Learning.

  2018cites this paper
• c-Raf in KRas Mutant Cancers: A Moving Target.

  2018cites this paper
• Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.

  2018cites this paper
• Functional Signature Ontology-Based Identification and Validation of Novel Therapeutic Targets and Natural Products for the Treatment of Cancer

  2018cites this paper
• MEK drives BRAF activation through allosteric control of KSR proteins

  2018cites this paper
• A feedback loop consisting of RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of colorectal cancer.

  2018cites this paper
• Biochemical analysis of Tribbles 2 pseudokinase using repurposed kinase inhibitors

  2018cites this paper
• PI3K: A Crucial Piece in the RAS Signaling Puzzle.

  2018cites this paper
• The potential of CRL4-DCAF1 and KSR1 as therapeutic targets in low-grade Merlin-deficient tumours

  2018cites this paper
• Cellular Complexity in MAPK Signaling in Plants: Questions and Emerging Tools to Answer Them

  2018cites this paper
• Structural snapshots of RAF kinase interactions.

  2018cites this paper
• The N-Terminal GTPase Domain of p190RhoGAP Proteins Is a PseudoGTPase.

  2018cites this paper
• Targeting the MAPK Pathway in RAS Mutant Cancers.

  2018influential citation
• The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms

  2018cites this paper
• Structure and evolution of the Fam20 kinases

  2018cites this paper
• Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.

  2018influential citation